Clinical Trial Update: Visual Outcome and Visual Quality After Bilateral Implantation of the AcrySof® IQ IOL Compared to MI60® and Tecnis® IOL [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing visual outcomes after bilateral implantation of the AcrySof IQ intraocular lens to MI60 and Tecnis lenses has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• AcrySof IQ IOL
• MI60 IOL
• Tecnis IOL

Snippet

Sponsor: Alcon Research | Conditions: Cataract | Phase 4 | Status: WITHDRAWN